BioXcel Therapeutics Inc

NASDAQ:BTAI 4:00:00 PM EDT

3.82

-0.07 (-1.80%)

5:00:04 PM EDT: $3.86 +0.04 (+1.05%)

Market Cap (Intraday)	111.82M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.76 Million
Adjusted EPS	-$0.91

See more estimates

10-Day MA	$3.93
50-Day MA	$3.50
200-Day MA	$12.87

See more pivots

BioXcel Therapeutics Inc Stock, NASDAQ:BTAI

555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511

United States of America

Phone: +1.475.238.6837

Number of Employees: 183

http://www.bioxceltherapeutics.com

Description

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.